Editorial
Published on 16 Sep 2022
Editorial: PTCL from genes to therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1014483
- 2,062 views
- 2 citations
Type at least 3 characters
1,748 articles
Articles
Mini Review
Published on 16 Sep 2022
Adult-onset hereditary myeloid malignancy and allogeneic stem cell transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.997530
- 3,152 views
- 3 citations
Case Report
Published on 15 Sep 2022
Case report: A rare case of acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1011023
- 1,998 views
- 4 citations
Brief Research Report
Published on 15 Sep 2022
Corneal perforation associated with ocular graft-versus-host disease
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.962250
- 1,943 views
- 8 citations
Original Research
Published on 15 Sep 2022
Clinical implication of minimal residual disease assessment by next-generation sequencing-based immunoglobulin clonality assay in pediatric B-acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.957743
- 2,361 views
- 5 citations
Case Report
Published on 15 Sep 2022
Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.970188
- 1,881 views
Original Research
Published on 14 Sep 2022
Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.895777
- 1,402 views
- 4 citations
Original Research
Published on 14 Sep 2022
Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.938550
- 3,835 views
- 4 citations
Case Report
Published on 13 Sep 2022
Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1012268
- 2,050 views
- 3 citations
Original Research
Published on 12 Sep 2022
Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.947492
- 7,047 views
- 3 citations
Brief Research Report
Published on 09 Sep 2022
Broad genomic workup including optical genome mapping uncovers a DDX3X: MLLT10 gene fusion in acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.959243
- 3,960 views
- 5 citations
Editorial
Published on 09 Sep 2022
Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1020185
- 1,584 views
- 1 citation
Case Report
Published on 08 Sep 2022
Graft-versus-host disease complicated with small bowel obstruction in children: A case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1002333
- 2,288 views
- 3 citations
Original Research
Published on 08 Sep 2022
Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in Myelodysplastic Syndromes
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.961473
- 3,349 views
- 5 citations
Editorial
Published on 07 Sep 2022
Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.991527
- 1,563 views
Review
Published on 02 Sep 2022
Unique role of DDX41, a DEAD-box type RNA helicase, in hematopoiesis and leukemogenesis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.992340
- 5,423 views
- 10 citations